UPCOMING EVENTS
Check back for upcoming event information.
PAST EVENTS
Sponsored by We Work For Health Texas
THBI and the We Work For Health Texas coalition host a discussion on the importance of clinical trials and research and development in advancing cures and treatments for patients, while also supporting the Texas economy.
Since 2004, biopharmaceutical research companies have conducted, and continue to conduct, more than 17,000 clinical trials of new medicines in Texas in collaboration with clinical research centers, hospitals, and local research institutions. These clinical trials investigate some of Texas’ biggest health care challenges, including asthma, arthritis, cancer, diabetes, cardiovascular disease, and gastrointestinal diseases.
THBI Member Briefing: TRUE Grant Program
With special guests Texas Higher Education Coordinating Board
BioTexas Cafe: Cardiovascular Education and Access to Treatment
Sponsored by Bristol Myers Squibb
According to the Texas Department of State Health Services, heart disease is the number one cause of death in Texas. The financial burden of heart disease and stroke is substantial. But there is good news. Prevention and treatment advances are helping patients live longer fuller lives. In 2021, vital research progressed on a variety of cardiovascular fronts such as kidney failure and obesity. Studies highlighted better ways to deliver care for stroke, heart failure and high blood pressure. And cutting-edge developments in the practice of precision medicine could improve the futures of old and young.
In recognition of American Heart Month, THBI and guest speakers discuss cardiovascular health prevention and treatment, what policies Texas can create to enable access to care, and the importance of supporting innovations in treatment for cardiovascular diseases. Guest Speakers include Senator Carol Alvarado, Texas Senate, Eduardo Sanchez, M.D., M.P.H., FAAFP, Chief Medical Officer for Prevention, American Heart Association, and Melvin Earl Klegerman, Ph.D., Professor, Division of Cardiology, Department of Internal Medicine, University of Texas Health Science Center - Houston
THBI, American Cancer Society Cancer Action Network and Regarding Cancer partnered for a special presentation recognizing the 50th Anniversary of the War on Cancer. As part of a broader look at the progress made in these past five decades, the conversation included new developments in the fight against cancer – including the development of Multi-Cancer Early Detection (MCED) and the Multi-Cancer Early Detection Screening Coverage Act (H.R. 1946), authored by special guest speaker U.S. Congressman Jodey Arrington.
Over the last 50 years, great strides have been made in the fight against cancer, but we still have a long way to go. New technologies, such as MCED, are game changers in the war against cancer and THBI, along with our partners in the cancer advocacy community, are eager to share why we consider these technologies crucial in reducing the burden of cancer among Texans.
American Cancer Society Cancer Action Network of Texas
The Promise of Precision Medicine
Biomarker testing is an important step to accessing precision medicine which includes targeted therapies that can lead to improved survivorship and better quality of life for cancer patients. Patients currently face limited and disparate access to biomarker testing. ACS CAN hosted a virtual education event to educate policymakers, partners and volunteers about biomarker testing and current barriers and lay groundwork to expand access to these vital tests.
THBI proudly co-hosted this event. View the recording below. You will need to login to access the video and then click on "Archived Events" on the left.
THBI President's Call with Special Guest, Greg Hansch
THBI and partner patient groups have been participating in the We Work For Health Texas Virtual Fly-In throughout July, meeting with Texas Congressional Members on issues affecting the life science industry and patient access. This call features host special guest Greg Hansch, Executive Director of National Alliance on Mental Illness (NAMI) Texas.
BioTexas Cafe: Heart Health Education
Sponsored by Bristol Myers Squibb
The discussion centered around policies relating to underserved areas, high prevalence of cardiovascular disease, the impact of COVID-19 and telemedicine. Guest speakers included: State Representative Nicole Collier, Nora Belcher and Maricela Wilson.
THBI President's Call with Special Guest, Mike Mattoon
This month's special guest, Mike Mattoon is the Vice President of Federal Government Relations at the Biotechnology Innovation Organization (BIO). Now that we're more than 100 days in with the new administration, we were excited to hear Mike provide a federal policy update.
THBI President's Call with Special Guest, Dana Harris
This month's special guest is Dana Harris, Vice President of Federal and State Advocacy at Austin Chamber. Dana provides a Texas 2050 Coalition legislative update.
THBI President's Call with Special Guest, Amy Walker
This month's special guest, Amy Walker, Director of Infectious Diseases Policy at BIO, provides a COVID update.
THBI President's Call with Special Guest, Khrystal K. Davis, JD
This month's special guest Khrystal K. Davis, JD, Founding President of Texas Rare Alliance provides an update with the 2021 Texas RARE priorities.
Life Science Economic Development Forum
In partnership with DPR Construction
January 27, 2021
The forum was a closed, invite-only meeting with THBI’s Economic Development and Workforce Leadership Council, life science company executives and state economic development teams. The meeting provided a platform for Life Science employers to begin a conversation about how the life science industry, and regions across the state, can collaborate to drive economic growth in Texas by attracting Life Science research and manufacturing facilities and provide careers, opportunities and ideas centered on innovation.
To learn more about THBI’s Economic Development and Workforce Leadership Council, and how to access these events, email julia@thbi.com.
BioTexas Cafe - Value in Innovation, Driving Patient Outcomes Through Scientific Advancements
Sponsored by Genentech, Novartis and Vertex
December 1, 2020
Join us for a policy discussion on the value of innovative genomic therapies, diagnostics and treatments, and alternative payment models. THBI's Policy Director Meredith Armstrong will lead this important conversation with guest speakers Tricia Fitzsimmons, Executive Director, Public Policy, Novartis, Scott McGoohan, JD, Senior Director, Government Affairs and Public Policy, Vertex Pharmaceuticals, and Casey O'Neill, Principal, Genentech.
THBI President's Calls are member-only events. To learn how to access these events, email julia@thbi.com.
THBI President's Call with Special Guest, Mike Mattoon
This month's special guest Mike Mattoon, Vice President of Federal Government Relations at Biotechnology Innovation Organization (BIO) joins us for a federal update as we head into the election. Mike shared with members what he is seeing as we are now one week away from very important federal elections, and shared an outlook on how the different outcomes could effect the life sciences industry.
THBI President's Calls are member-only events. To learn how to access these events, email julia@thbi.com.
BioTexas Cafe - The Promise of Personalized Medicine: CAR T-Cell Therapy
Sponsored by Bristol Myers Squibb
October 15, 2020
Special guest Dr. Michele Sharr McMahon, Director, Global Drug Development at Bristol Myers Squibb shares the work of her and her team on Novel cell-based therapies, such as CAR T, that use a person’s own cells are unlocking new potential in the fight against some of the most difficult-to-treat cancers. As a company on the forefront of scientific innovation, Bristol Myers Squibb is evaluating new and next-generation cell therapies and investing in technology to ensure that our health care system continues to support the development and access for these personalized treatments for patients today, and for the future.
THBI President's Call with Special Guest, Elliott Francis
Tom Kowalski, THBI's President and CEO, speaks with Elliott M. Francis, Director of Diversity and Inclusion at Biotechnology Innovation Organization (BIO). Elliott shares insight on his leadership role to drive change through the development and implementation of strategic diversity and inclusion initiatives in the biotechnology and life sciences industry, and within BIO.
BioTexas Cafe - A Discussion on COVID-19 Vaccines and Therapeutics
Co-Hosted by Texas Association of Manufacturers
In partnership with Texas Association of Manufacturers (TAM), Tom Kowalski, President and CEO of THBI, Tony Bennett, President and CEO of TAM, and our member companies provide an update on COVID-19 vaccines and therapeutics and how companies produce and distribute these products.
The Latest on COVID-19, A Town Hall Discussion
Sponsored by Amgen
THBI President's Call with Special Guest Wayne Roberts
THBI President's Call with Special Guests Tony Mitchell and Scott Newkirk
THBI President's Call with Special Guest Emma Schwartz
COVID-19 and the Important Role of Manufacturing
COVID-19 and the Importance of Policy on Public Health
This presentation was focused on the importance of public policy in fighting public health crises. Dr. Rodney Rohde, Professor and Chair for the Clinical Laboratory Science (CLS) Program in the College of Health Professions at Texas State University and Tom Kowalski, CEO of THBI discuss best practices policy leaders can learn from COVID-19 and how to be better prepared for the next virus.
THBI COVID-19 Webinar with Texas Biomedical Research Institute
Hear the latest COVID-19 research and development efforts being conducted at the Texas Biomedical Research Institute campus in San Antonio. Dr. Larry Schlesinger, CEO and Dr. Joanne Turner, Vice President for Research will discuss the Institute’s unique role in the bioscience landscape and how its team of researchers are tackling the newest threat – COVID-19 – followed by a Q&A!